Management

Zydus Cadila files anti-diabetic drug application with DCGI

Healthcare services provider Zydus Cadila has filed an application before the Drugs Controller General of India (DCGI) for its anti-diabetic drug. The company has filed an investigational new drug (IND) application before the DCGI for its ZYD1 drug, used in the treatment of diabetes, Cadila Healthcare, the flagship company of Zydus Cadila group, said in a filing to the Bombay Stock Exchange. The global anti-diabetic market is estimated at Rs 24 billion dollars in 2008.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Kakodkar rules out FDI in nuclear plants
Chairman of the Atomic energy Commission (AEC) Anil Kakodkar has ruled out Foreign Direct Investment (FDI) in nuclear power plants, but said there were no restrictions for the private sector to manufacture nuclear equipment and construction.
Popular Articles

Mfg slows down in Aug, domestic demand drives growth: PMI
The growth in domestic manufacturing sector slowed down in August though the domestic demand continued to drive recovery despite lower margins. The HSBC Market Manufacturing Purchasing Managers Index (PMI), a seasonally adjusted headline index designed to measure the overall health of the manufacturing sector, stood at 53.2 last month down from 55.4 in July.

Fuel retailers for freeing petrol, diesel prices
Reliance Industries (RIL) and Essar Oil were today joined by state-run Indian Oil Corp (IOC) and Oil and Natural Gas Corp (ONGC) in criticising the government"s "hotchpotch" fuel pricing policy which they alleged had ruined public sector firms and state finances, and demanded freeing of petrol and diesel prices immediately.

© Copyright 2009